OasisLMS

At the end of this activity, participants will be able to:

1. Assess and calculate atherosclerotic cardiovascular disease (ASCVD) risk for patients with dyslipidemia, establishing individualized lipid goals based on patient demographics, comorbidities, and guideline-recommended targets.
2. Develop evidence-based treatment plans for dyslipidemia incorporating lifestyle modifications and pharmacological therapies, using shared decision-making to counsel patients on dietary interventions, exercise, and other modifiable risk factors.
3. Apply knowledge of pharmacotherapy options and emerging treatments in clinical scenarios, adjusting management strategies based on patient response, statin intolerance, or contraindications.
4. Develop individualized dyslipidemia management strategies for special populations, such as patients with diabetes, severe hypertriglyceridemia (HTG), chronic kidney disease (CKD), and post-transplant.
5.  Address clinical challenges like statin intolerance and severe HTG by applying evidence-based guidelines to optimize treatment outcomes and minimize adverse effects.

Physician Credit

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.  

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.  

Disclosures and Conflicts of Interest Policy

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved.

AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.  

Planner Disclosures 

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Faculty Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Reviewer Disclosures

None of the reviewers for this educational activity have any relevant financial relationships with ineligible companies to disclose.